Researchers at Israel’s Technion Institute genetically modified muscle stem cells from diabetic mice to express high levels of GLUT4 molecules, which transport glucose in the body. When re-implanted into the mice, it reduced blood sugar levels by an average of 26% and lowered levels of fatty liver.
https://www.jns.org/technion-biomed-engineers-assess-novel-approach-to-treating-type-2-diabetes/